Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Liabilities and Shareholders Equity (2016 - 2025)

Gsk has reported Liabilities and Shareholders Equity over the past 10 years, most recently at $81.3 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $81.3 billion for Q4 2025, up 6.52% from a year ago — trailing twelve months through Dec 2025 was $301.4 billion (down 7.75% YoY), and the annual figure for FY2025 was $81.3 billion, up 6.52%.
  • Liabilities and Shareholders Equity for Q4 2025 was $81.3 billion at Gsk, up from $76.3 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for GLAXF hit a ceiling of $106.6 billion in Q4 2021 and a floor of $70.5 billion in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $76.3 billion (2024), compared with a mean of $81.6 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: tumbled 33.84% in 2022 and later increased 6.52% in 2025.
  • Gsk's Liabilities and Shareholders Equity stood at $106.6 billion in 2021, then crashed by 33.84% to $70.5 billion in 2022, then rose by 3.81% to $73.2 billion in 2023, then grew by 4.21% to $76.3 billion in 2024, then rose by 6.52% to $81.3 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $81.3 billion (Q4 2025), $76.3 billion (Q4 2024), and $73.2 billion (Q4 2023) per Business Quant data.